Ascletis Pharma Inc. (1672.HK)

HKD 6.55

(3.15%)

Gross Profit Summary of Ascletis Pharma Inc.

Ascletis Pharma Inc.'s latest annual gross profit in 2023 was 25.99 Million CNY , up 205.26% from previous year.
Ascletis Pharma Inc.'s latest quarterly gross profit in 2024 Q2 was - CNY , down 0.0% from previous quarter.
Ascletis Pharma Inc. reported a annual gross profit of -24.69 Million CNY in annual gross profit 2022, down -163.03% from previous year.
Ascletis Pharma Inc. reported a annual gross profit of 39.17 Million CNY in annual gross profit 2021, up 266.71% from previous year.
Ascletis Pharma Inc. reported a quarterly gross profit of - CNY for 2024 Q2, down 0.0% from previous quarter.
Ascletis Pharma Inc. reported a quarterly gross profit of 19.31 Million CNY for 2023 Q1, up 178.72% from previous quarter.

Annual Gross Profit Chart of Ascletis Pharma Inc. (2023 - 2016)

Historical Annual Gross Profit of Ascletis Pharma Inc. (2023 - 2016)

Year	Gross Profit	Gross Profit Growth
2023	25.99 Million CNY	205.26%
2022	-24.69 Million CNY	-163.03%
2021	39.17 Million CNY	266.71%
2020	-23.49 Million CNY	-118.91%
2019	124.28 Million CNY	-19.27%
2018	153.94 Million CNY	189.36%
2017	53.2 Million CNY	61.34%
2016	32.97 Million CNY	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	- CNY	100.0%
2024 Q2	- CNY	0.0%
2023 Q1	19.31 Million CNY	178.72%
2023 FY	25.99 Million CNY	205.26%
2023 Q4	-6.31 Million CNY	0.0%
2023 Q3	-6.31 Million CNY	-132.7%
2023 Q2	19.31 Million CNY	0.0%
2022 FY	-24.69 Million CNY	-163.03%
2022 Q4	-24.52 Million CNY	0.0%
2022 Q3	-24.52 Million CNY	-301.33%
2022 Q2	12.18 Million CNY	0.0%
2022 Q1	12.18 Million CNY	-37.39%
2021 Q3	19.46 Million CNY	1620.35%
2021 Q2	-1.28 Million CNY	0.0%
2021 FY	39.17 Million CNY	266.71%
2021 Q4	19.46 Million CNY	0.0%
2021 Q1	-1.28 Million CNY	95.18%
2020 Q4	-26.58 Million CNY	0.0%
2020 Q3	-26.58 Million CNY	-470.49%
2020 Q2	7.17 Million CNY	0.0%
2020 Q1	7.17 Million CNY	-79.09%
2020 FY	-23.49 Million CNY	-118.91%
2019 Q3	34.3 Million CNY	23.23%
2019 FY	124.28 Million CNY	-19.27%
2019 Q4	34.3 Million CNY	0.0%
2019 Q1	27.83 Million CNY	33.78%
2019 Q2	27.83 Million CNY	0.0%
2018 Q2	61.26 Million CNY	19.98%
2018 Q3	20.8 Million CNY	-66.03%
2018 Q4	20.8 Million CNY	0.0%
2018 FY	153.94 Million CNY	189.36%
2018 Q1	51.06 Million CNY	283.91%
2017 Q1	13.3 Million CNY	0.0%
2017 FY	53.2 Million CNY	61.34%
2017 Q2	13.3 Million CNY	-0.01%
2017 Q4	13.3 Million CNY	0.0%
2017 Q3	13.3 Million CNY	0.0%
2016 FY	32.97 Million CNY	0.0%

Peer Gross Profit Comparison of Ascletis Pharma Inc.

Name	Gross Profit	Gross Profit Difference
Uni-Bio Science Group Limited	392.81 Million HKD	93.384%
CK Life Sciences Int'l., (Holdings) Inc.	947.7 Million HKD	97.258%